Jump to Navigation

Cytonome has assembled a team of managers with over 100 man years experience in instrument design, applied biollogical science, public accounting and business development.    The Cytonome team is uniquely positioned to bring the revolutionary Gigasort technology to market.

  • John C. Sharpe, Ph.D.
    Chief Executive Officer

    Dr John C Sharpe is the Chief Executive Officer of CytonomeST. He has over two decades of experience in developing and commercializing advanced cellular analysis and purification technologies. He was a former Director of R&D at DakoCytomation, Director of Photara Technologies Ltd, and Business Manager for DairyNZ. In these and other roles, Dr Sharpe has led numerous product development and other commercial initiatives, and due diligence studies for technology acquisitions.  Dr Sharpe holds a Ph.D. from The University of Waikato.

  • Lydia Villa-Komaroff Ph.D.
    Chief Scientific Officer

    Dr. Lydia Villa-Komaroff is the Chief Scientific Officer at CytonomeST. During her 20 year research career, Dr. Villa-Komaroff has held positions at MIT, Harvard University, University of Massachusetts Medical School and Harvard Medical School.  As a science administrator, she has been VP for Research at Northwestern University in Illinois and the Vice President for Research and Chief Operating Officer of Whitehead Institute for Biomedical Research in Cambridge, MA.  She also served as Chair of the Board of Directors of Transkaryotic Therapies.

  • Jack Lapidas, MBA
    Vice President of Business Development

    Jack Lapidas is the Vice President of Business Development at CytonomeST. Mr. Lapidas previously led Coventor's business development efforts in its microfluidics and biotechnology division and has more than 10 years of executive level business development and marketing experience.  He holds Bachelor of Science and Master of Business Administration degrees from Cornell University.

  • Heather Kiessling, MBA
    Vice President of Finance

    Heather Kiessling is the Vice President of Finance at CytonomeST. Prior to joining CytonomeST as VP Finance, Ms. Kiessling was the Treasurer and Director of Finance for AutoImmune Inc, a biopharmaceutical company. She has a Bachelor of Arts from the University of California, San Diego, and a Master of Business Administration from the University of Michigan.